Literature DB >> 20118899

Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2alpha in interstitial fibroblasts of the renal cortex.

Hayo Castrop1, Armin Kurtz.   

Abstract

Erythropoietin (EPO) is the central hormone in the regulation of erythropoiesis. Synthesis of EPO and its constitutive release into the circulation are controlled by the transcriptional activity of the EPO gene. A key regulator of EPO is the dimeric hypoxia-inducible transcription factor (HIF), which has three isoforms. Paliege and co-workers provide convincing morphological evidence that it is the HIF-2 isoform that essentially triggers EPO in the kidney, which is the primary source of EPO in the body.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118899     DOI: 10.1038/ki.2009.470

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Rhodiola crenulata- and Cordyceps sinensis-based supplement boosts aerobic exercise performance after short-term high altitude training.

Authors:  Chung-Yu Chen; Chien-Wen Hou; Jeffrey R Bernard; Chiu-Chou Chen; Ta-Cheng Hung; Lu-Ling Cheng; Yi-Hung Liao; Chia-Hua Kuo
Journal:  High Alt Med Biol       Date:  2014-09       Impact factor: 1.981

2.  Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells.

Authors:  Redona Hafizi; Faik Imeri; Bisera Stepanovska Tanturovska; Roxana Manaila; Stephanie Schwalm; Sandra Trautmann; Roland H Wenger; Josef Pfeilschifter; Andrea Huwiler
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

3.  Multilevel regulation of HIF-1 signaling by TTP.

Authors:  Michael Fähling; Anja Bondke Persson; Bertram Klinger; Edgar Benko; Andreas Steege; Mumtaz Kasim; Andreas Patzak; Pontus B Persson; Gunter Wolf; Nils Blüthgen; Ralf Mrowka
Journal:  Mol Biol Cell       Date:  2012-08-23       Impact factor: 4.138

4.  Impaired erythropoietin synthesis in chronic kidney disease is caused by alterations in extracellular matrix composition.

Authors:  Gemma Olmos; José M Muñoz-Félix; Inés Mora; Anton Gerhard Müller; Maria Piedad Ruiz-Torres; José M López-Novoa; Diego Rodríguez-Puyol
Journal:  J Cell Mol Med       Date:  2017-08-30       Impact factor: 5.310

Review 5.  Alteration of the DNA Methylation Signature of Renal Erythropoietin-Producing Cells Governs the Sensitivity to Drugs Targeting the Hypoxia-Response Pathway in Kidney Disease Progression.

Authors:  Koji Sato; Naonori Kumagai; Norio Suzuki
Journal:  Front Genet       Date:  2019-11-13       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.